Anixa Biosciences, Inc. - Common Stock (NQ:ANIX)

3.070 +0.020 (+0.66%)

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 4, 2026 Add to My Watchlist

Price and Volume

Volume	365,897
Open	3.030
Bid (Size)	3.040 (100)
Ask (Size)	3.110 (100)
Prev. Close	3.050
Today's Range	3.000 - 3.105
52wk Range	2.320 - 5.457
Shares Outstanding	33,527,858
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

July 17, 2026

Gainers Anixa Biosciences (NASDAQ:ANIX) shares rose 10.0% to $3.65 during Friday's pre-market session. The market value of their outstanding shares is at $112.9 million. Barinthus Biotherapeutics...

Via Benzinga

Anixia Biosciences and OwlTing Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

May 01, 2026

Via ACCESS Newswire

Performance

YTD	-2.8%	-2.8%
1 Month	-10.0%	-10.0%
3 Month	+17.2%	+17.2%
6 Month	+6.2%	+6.2%
1 Year	+2.7%	+2.7%

More News

Replays from RedChip's Biotech Investor Conference Now Available

April 20, 2026

Via ACCESS Newswire

RedChip's April 16 Virtual Investor Conference to Highlight Companies Driving the Next Wave of Biotech Innovation

April 10, 2026

Via ACCESS Newswire

Recap: Anixa Biosciences Q1 Earnings ↗

March 12, 2024

Via Benzinga

BioMedNewsBreaks — Anixa Biosciences, Inc. (NASDAQ: ANIX) CAR-T Co-Inventor To Keynote SCTR 2026 Retreat

February 25, 2026

Via Investor Brand Network

Water Tower Research Publishes Initiation of Coverage Report on Anixa Biosciences, Inc., “Anixa’s T-Cell Innovations Show Breakthrough Potential in Solid Tumors”

January 21, 2026

Via TheNewswire.com

3 Under-the-Radar Biotechs Under $5 That Could Soar 200% ↗

September 09, 2025

Via MarketBeat

EXCLUSIVE: Anixa Biosciences Receives Key US Patent Nod For Breast Cancer Vaccine Patent ↗

April 09, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

April 08, 2025

Via Benzinga

EXCLUSIVE: Anixa Biosciences Inks Letter of Intent with Austria-Based VERDI Solutions To Develop AI-Guided Personalized Cancer Vaccines ↗

March 25, 2025

Via Benzinga

EXCLUSIVE: Anixa Biosciences Poised To Receive US Patent For Ovarian Cancer Vaccine ↗

March 24, 2025

Via Benzinga

This ACNB Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday ↗

March 21, 2025

Via Benzinga

iAccess Alpha's Buyside Best Ideas Virtual Winter Conference December 10-11, 2024

December 06, 2024

Via ACCESSWIRE

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 30, 2024

Via Benzinga

Anixa Biosciences And 3 Other Stocks Under $5 Insiders Are Buying ↗

July 29, 2024

Via Benzinga

EXCLUSIVE: FDA Approves Anixa Biosciences' Individual Patient Trial Application For Ovarian Cancer CAR-T Therapy ↗

July 23, 2024

Via Benzinga

EXCLUSIVE: Anixa Biosciences Finds Stock Undervalued, Launches $5M Stock Buyback Program ↗

July 15, 2024

Via Benzinga

ANIX Stock Earnings: Anixa Biosciences Beats EPS for Q2 2024 ↗

June 04, 2024

Via InvestorPlace

7 Penny Biotech Stocks to Triple Your Investment ↗

May 28, 2024

Via InvestorPlace

Anixa Biosciences, Inc. (NASDAQ: ANIX) Featured in Coverage of the EF Hutton Annual Global Conference

May 16, 2024

Via Investor Brand Network

Sidoti Events, LLC's Virtual May Micro-Cap Conference

May 07, 2024

Via ACCESSWIRE

Anixa Biosciences (NASDAQ:ANIX) Gains Attention for Its Innovative Cancer Therapies Amid Biopharma Sector Growth

March 20, 2024

Via AB Newswire

Sidoti Events, LLC's Virtual January Micro-Cap Conference

January 15, 2024

Via ACCESSWIRE

Anixa Biosciences, A New Type Of Biotech Company: Could It Disrupt The Cancer Landscape? ↗

December 20, 2023

Via Benzinga

Frequently Asked Questions

Is Anixa Biosciences, Inc. - Common Stock publicly traded?

Yes, Anixa Biosciences, Inc. - Common Stock is publicly traded.

What exchange does Anixa Biosciences, Inc. - Common Stock trade on?

Anixa Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Anixa Biosciences, Inc. - Common Stock?

The ticker symbol for Anixa Biosciences, Inc. - Common Stock is ANIX on the Nasdaq Stock Market

What is the current price of Anixa Biosciences, Inc. - Common Stock?

The current price of Anixa Biosciences, Inc. - Common Stock is 3.070

When was Anixa Biosciences, Inc. - Common Stock last traded?

The last trade of Anixa Biosciences, Inc. - Common Stock was at 09/04/26 04:00 PM ET

What is the market capitalization of Anixa Biosciences, Inc. - Common Stock?

The market capitalization of Anixa Biosciences, Inc. - Common Stock is 102.93M

How many shares of Anixa Biosciences, Inc. - Common Stock are outstanding?

Anixa Biosciences, Inc. - Common Stock has 103M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.